BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Omeros Corporation Reports Fourth Quarter and Year-End 2024 Financial Results

  March 31, 2025

   · 

  20 min read
• Press Releases

  Geron Plans to Announce First Quarter 2025 Financial Results on May 7, 2025

  March 31, 2025

   · 

  1 min read
• Press Releases

  Hoth Therapeutics Receives USPTO Filing Receipt for HT-001 Formulation Patent Application, Expanding Existing Patent Coverage

  March 31, 2025

   · 

  4 min read
• Press Releases

  European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11

  March 31, 2025

   · 

  6 min read
• Press Releases

  FDA Issues Complete Response Letter for Etripamil for PSVT

  March 31, 2025

   · 

  5 min read
• Press Releases

  FibroGen Announces Publication of Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer in the Journal of Clinical Oncology

  March 31, 2025

   · 

  8 min read
• Press Releases

  60 Degrees Pharmaceuticals Announces 2024 Annual Results

  March 31, 2025

   · 

  7 min read
• Press Releases

  Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851

  March 31, 2025

   · 

  5 min read
• Press Releases

  Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress

  March 31, 2025

   · 

  8 min read
• Press Releases

  LAVA Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

  March 31, 2025

   · 

  12 min read